Entity Type
Company
SEC filings, ownership reports, and insider transactions for CIK 0002008861.
Entity Type
Company
Total Filings
87
Latest Filing
05 Aug 2025
Industry
Pharmaceutical Preparations
Keep this page in your research queue, then return to compare new filings with prior context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Best next steps
Start with the latest filings table, then open the strongest context page for this filer.
15-15D filed on 05 Aug 2025 for CIK 0002008861.
15-15D filed on 05 Aug 2025 for CIK 0002008861.
Return Loop
A newly filed 15-15D can change the filing history, ownership context, or next research path for Endo LP.
Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.
Latest update
Latest financial period: Q1 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
12 May 2025
Page type
Company facts
Latest period
Q1 2025
SEC-backed company facts were refreshed from filings filed on 12 May 2025.
Benchmark Context
Endo LP has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q1 2025. That gives you a fresh baseline before you compare this company with peers.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
Endo LP has filed 87 SEC EDGAR filings since 21 Mar 2024. Common forms include 15-15D, EFFECT, S-8 POS, POS AM and more.
Recent SEC filings for Endo LP with direct links to document and filing folders.
Endo LP files with the SEC under CIK 0002008861. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.